Lapsed Apr 14, 2017 on the fee record · High confidence
20-year base term ended Nov 6, 2026
Second maintenance fee unpaid; grace period ended.
Held by Hologic, Inc.
Filed Nov 6, 2006 as application 11/593,678 · Granted Apr 14, 2009
Base term, 20 years from filing, plus 40 days of patent term adjustment (USPTO delay)
Today
Lapsed Apr 14, 2017
2006
2026
Clock starts
Nov 6, 2006
Nov 6, 2006
No longer in force
Apr 14, 2017
Apr 14, 2017
Granted
Apr 14, 2009
Apr 14, 2009
Term would have run to
Dec 16, 2026
Dec 16, 2026
base term
patent term adjustment
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
40
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
20
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
Its term would have run to Dec 16, 2026: its 20-year base term plus 40 days of term adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 6, 2006, when this application, 11/593,678, was filed | Nov 6, 2026 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +40 days, USPTO patent term adjustment record | Dec 16, 2026 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | lapsed Apr 14, 2017 | High confidence |
| Computed term end | The steps above, in order | Apr 14, 2017 | High confidence |
This family
| US 7,413,539 | Term ended Nov 2025 | Nov 2025 |
| US 8,079,946 | In force Apr 2029 | Apr 2029 |
| US 7,465,268 | Lapsed on the fee record Dec 2020 | Dec 2020 |
| US 7,517,310 | this patent Apr 2017 | Apr 2017 |
| US 7,407,476 | Term ended no later than Nov 2026 | no later than Nov 2026 |
| Application PCT/US2006/043891 | PCT application no patent term | no patent term |
| Application PCT/US2006/044067 | PCT application no patent term | no patent term |
| US 8,057,379 | Term ended Nov 2025 | Nov 2025 |
8 of 20 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 30, 2007 Reel 18827, frame 718 | Lubock, Paul; Jones, Michael L. | Senorx, Inc. | Assignment of Assignor's Interest |
| Jun 3, 2013 Reel 30530, frame 229 | Senorx, Inc. | Hologic, Inc. | Assignment of Assignor's Interest |
| Jul 9, 2013 Reel 30755, frame 31 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiogrphy Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-probe, Incorporated | Goldman Sachs Bank USA | Security Agreement |
| Jul 17, 2015 Reel 36127, frame 538 | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc.; Gen-Probe Incorporated | Security Interest Release R/F 030755 0031 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Hologic, Inc. | Security Interest Release R/F 030755 0031 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Biolucent, LLC | Security Interest Release R/F 030755 0031 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Corporation | Security Interest Release R/F 030755 0031 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Cytyc Surgical Products, Limited Partnership | Security Interest Release R/F 030755 0031 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Direct Radiography Corp. | Security Interest Release R/F 030755 0031 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Suros Surgical Systems, Inc. | Security Interest Release R/F 030755 0031 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Third Wave Technologies, Inc. | Security Interest Release R/F 030755 0031 |
| Jul 17, 2015 reel/frame not recorded | Goldman Sachs Bank USA, as Collateral Agent | Gen-Probe Incorporated | Security Interest Release R/F 030755 0031 |
| Aug 7, 2015 Reel 36307, frame 199 | Hologic, Inc.; Biolucent, LLC; Cytyc Corporation; Cytyc Surgical Products, Limited Partnership; Direct Radiography Corp.; Gen-Probe Incorporated; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc.; Third Wave Technologies, Inc. | Bank of America, N.A., as Collateral Agent | Security Agreement |
| Apr 28, 2026 Reel 75566, frame 39 | Bank of America, N.A., as Collateral Agent | Hologic, Inc., on Its Own Behalf and as Successor-by-Merger to Direct Radiography Corp.; Cytyc Corporation, on Its Own Behalf and as Successor-by-Merger to Biolucent, LLC; Cytyc Surgical Products, LLC, as Successor-by-Conversion to Cytyc Surgical Products, Limited Partnership; Gen-Probe Incorporated, on Its Own Behalf and as Successor-by-Merger to Third Wave Technologies, Inc.; Gen-Probe Prodesse, Inc.; Suros Surgical Systems, Inc. | Release of Security Interest |
| Apr 28, 2026 reel/frame not recorded | Bank of America, N.A., as Collateral Agent | Hologic, Inc., on Its Own Behalf and as Successor-by-Merger to Direct Radiography Corp. | Release of Security Interest |
| Apr 28, 2026 reel/frame not recorded | Bank of America, N.A., as Collateral Agent | Cytyc Corporation, on Its Own Behalf and as Successor-by-Merger to Biolucent, LLC | Release of Security Interest |
| Apr 28, 2026 reel/frame not recorded | Bank of America, N.A., as Collateral Agent | Cytyc Surgical Products, LLC, as Successor-by-Conversion to Cytyc Surgical Products, Limited Partnership | Release of Security Interest |
| Apr 28, 2026 reel/frame not recorded | Bank of America, N.A., as Collateral Agent | Gen-Probe Incorporated, on Its Own Behalf and as Successor-by-Merger to Third Wave Technologies, Inc. | Release of Security Interest |
| Apr 28, 2026 reel/frame not recorded | Bank of America, N.A., as Collateral Agent | Gen-Probe Prodesse, Inc. | Release of Security Interest |
| Apr 28, 2026 reel/frame not recorded | Bank of America, N.A., as Collateral Agent | Suros Surgical Systems, Inc. | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Note
The 40 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
45
later US patents cite this one
That is top 25% of utility patents granted in 2009 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.